Hot dots – which nodes should be removed in sentinel lymph node biopsy for melanoma?

References

• Morton DL, Thompson JF, Cochran AJ, et al. Final trial report of sentinel-node biopsy versus nodal observation in melanoma. N Engl J Med. 2014;370(7):599–609. doi: 10.1056/NEJMoa1310460.
   PubMed Web of Science ®Google Scholar
• Gershenwald JE, Scolyer RA, Hess KR, et al. Melanoma staging: evidence-based changes in the American joint committee on cancer eighth edition cancer staging manual. CA Cancer J Clin. 2017;67(6):472–492. doi: 10.3322/caac.21409.
   PubMed Web of Science ®Google Scholar
• Faries MB, Thompson JF, Cochran AJ, et al. Completion dissection or observation for Sentinel-Node metastasis in melanoma. N Engl J Med. 2017;376(23):2211–2222. doi: 10.1056/NEJMoa1613210.
   PubMed Web of Science ®Google Scholar
• Leiter U, Stadler R, Mauch C, et al. Complete lymph node dissection versus no dissection in patients with sentinel lymph node biopsy positive melanoma (DeCOG-SLT): a multicentre, randomised, phase 3 trial. Lancet Oncol. 2016;17(6):757–767. doi: 10.1016/S1470-2045(16)00141-8.
   PubMed Web of Science ®Google Scholar
• Wong SL, Faries MB, Kennedy EB, et al. Sentinel lymph node biopsy and management of regional lymph nodes in melanoma: american society of clinical oncology and society of surgical oncology clinical practice guideline update. Ann Surg Oncol. 2018;25(2):356–377. doi: 10.1245/s10434-017-6267-7.
   PubMed Web of Science ®Google Scholar
• Eggermont AM, Chiarion-Sileni V, Grob JJ, et al. Prolonged survival in stage III melanoma with ipilimumab adjuvant therapy. N Engl J Med. 2016;375(19):1845–1855. doi: 10.1056/NEJMoa1611299.
   PubMed Web of Science ®Google Scholar
• Long GV, Hauschild A, Santinami M, et al. Adjuvant dabrafenib plus trametinib in stage III BRAF-Mutated melanoma. N Engl J Med. 2017;377(19):1813–1823. doi: 10.1056/NEJMoa1708539.
   PubMed Web of Science ®Google Scholar
• Weber J, Mandala M, Del Vecchio M, et al. Adjuvant nivolumab versus ipilimumab in resected stage III or IV melanoma. N Engl J Med. 2017;377(19):1824–1835. doi: 10.1056/NEJMoa1709030.
   PubMed Web of Science ®Google Scholar
• Morton DL, Wen DR, Wong JH, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg. 1992;127(4):392–399. doi: 10.1001/archsurg.1992.01420040034005.
   PubMed Web of Science ®Google Scholar
• Thompson JF, Uren RF. What is a ‘sentinel’ lymph node? Eur J Surg Oncol. 2000;26(2):103–104. doi: 10.1053/ejso.1999.0752.
   PubMedGoogle Scholar
• Morton DL, Cochran AJ, Thompson JF, et al. Sentinel node biopsy for early-stage melanoma: accuracy and morbidity in MSLT-I, an international multicenter trial. Ann Surg. 2005;242(3):302–311. doi: 10.1097/01.sla.0000181092.50141.fa.
   PubMed Web of Science ®Google Scholar
• Nieweg OE, Jansen L, Kroon BB. Technique of lymphatic mapping and sentinel node biopsy for melanoma. Eur J Surg Oncol. 1998;24(6):520–524. doi: 10.1016/s0748-7983(98)93428-x.
   PubMedGoogle Scholar
• Uren RF, Howman-Giles R, Thompson JF. Patterns of lymphatic drainage from the skin in patients with melanoma. J Nuc Med. 2003;44(4):570–582.
   PubMed Web of Science ®Google Scholar
• Vuoristo M, Muhonen T, Koljonen V, et al. Pelvic sentinel lymph nodes have minimal impact on survival in melanoma patients. BJS Open. 2021;5(6):zrab128. doi: 10.1093/bjsopen/zrab128.
   PubMed Web of Science ®Google Scholar
• Carlson GW, Murray DR, Thourani V, et al. The definition of the sentinel lymph node in melanoma based on radioactive counts. Ann Surg Oncol. 2002;9(9):929–933. doi: 10.1007/BF02557533.
   PubMed Web of Science ®Google Scholar
• Liu LC, Parrett BM, Jenkins T, et al. Selective sentinel lymph node dissection for melanoma: importance of harvesting nodes with lower radioactive counts without the need for blue dye. Ann Surg Oncol. 2011;18(10):2919–2924. doi: 10.1245/s10434-011-1689-0.
   PubMed Web of Science ®Google Scholar
• McMasters KM, Reintgen DS, Ross MI, et al. Sentinel lymph node biopsy for melanoma: how many radioactive nodes should be removed? Ann Surg Oncol. 2001;8(3):192–197. doi: 10.1007/s10434-001-0192-4.
   PubMed Web of Science ®Google Scholar
• Porter GA, Ross MI, Berman RS, et al. How many lymph nodes are enough during sentinel lymphadenectomy for primary melanoma? Surgery. 2000;128(2):306–311. doi: 10.1067/msy.2000.107418.
   PubMed Web of Science ®Google Scholar
• Ranson JM, Pantelides NM, Pandit DG, et al. Sentinel lymph node biopsy in melanoma: which hot nodes should be harvested and is blue dye really necessary? J Plast Reconstr Aesthet Surg. 2018;71(9):1269–1273. doi: 10.1016/j.bjps.2018.04.020.
   PubMed Web of Science ®Google Scholar
• Gershenwald JE, Andtbacka RH, Prieto VG, et al. Microscopic tumor burden in sentinel lymph nodes predicts synchronous nonsentinel lymph node involvement in patients with melanoma. J Clin Oncol. 2008;26(26):4296–4303. doi: 10.1200/JCO.2007.15.4179.
   PubMed Web of Science ®Google Scholar
• Satzger I, Leiter U, Grager N, et al. Melanoma-specific survival in patients with positive sentinel lymph nodes: relevance of sentinel tumor burden. Eur J Cancer. 2019;123:83–91. doi: 10.1016/j.ejca.2019.07.004.
   PubMed Web of Science ®Google Scholar
• van Akkooi AC, de Wilt JH, Verhoef C, et al. Clinical relevance of melanoma micrometastases (<0.1 mm) in sentinel nodes: are these nodes to be considered negative? Ann Oncol. 2006;17(10):1578–1585. doi: 10.1093/annonc/mdl176.
   PubMed Web of Science ®Google Scholar
• Vuoristo M, Muhonen T, Koljonen V, et al. Long-term prognostic value of sentinel lymph node tumor burden in survival of melanoma patients. Acta Oncol. 2021;60(6):803–807. doi: 10.1080/0284186X.2021.1892820.
   PubMed Web of Science ®Google Scholar
• Egger ME, Bower MR, Czyszczon IA, et al. Comparison of sentinel lymph node micrometastatic tumor burden measurements in melanoma. J Am Coll Surg. 2014;218(4):519–528. doi: 10.1016/j.jamcollsurg.2013.12.014.
   PubMed Web of Science ®Google Scholar
• van Akkooi AC, Nowecki ZI, Voit C, et al. Sentinel node tumor burden according to the rotterdam criteria is the most important prognostic factor for survival in melanoma patients: a multicenter study in 388 patients with positive sentinel nodes. Ann Surg. 2008;248(6):949–955. doi: 10.1097/SLA.0b013e31818fefe0.
   PubMed Web of Science ®Google Scholar
• Verwer N, Scolyer RA, Uren RF, et al. Treatment and prognostic significance of positive interval sentinel nodes in patients with primary cutaneous melanoma. Ann Surg Oncol. 2011;18(12):3292–3299. doi: 10.1245/s10434-011-1988-5.
   PubMed Web of Science ®Google Scholar
• Crystal JS, Thompson JF, Hyngstrom J, et al. Therapeutic value of sentinel lymph node biopsy in patients with melanoma: a randomized clinical trial. JAMA Surg. 2022;157(9):835–842.
   PubMed Web of Science ®Google Scholar
• Wrightson WR, Wong SL, Edwards MJ, et al. Complications associated with sentinel lymph node biopsy for melanoma. Ann Surg Oncol. 2003;10(6):676–680. doi: 10.1245/aso.2003.10.001.
   PubMed Web of Science ®Google Scholar
• Kretschmer L, Thoms KM, Peeters S, et al. Postoperative morbidity of lymph node excision for cutaneous melanoma-sentinel lymphonodectomy versus complete regional lymph node dissection. Melanoma Res. 2008;18(1):16–21. doi: 10.1097/CMR.0b013e3282f2017d.
   PubMed Web of Science ®Google Scholar
• Abou-Nukta F, Ariyan S. Sentinel lymph node biopsies in melanoma: how many nodes do we really need? Ann Plast Surg. 2008;60(4):416–419. doi: 10.1097/SAP.0b013e31812c65e2.
   PubMed Web of Science ®Google Scholar
• Chagpar AB, Scoggins CR, Martin RC, II, et al. Are 3 sentinel nodes sufficient? Arch Surg. 2007;142(5):456–459. doi: 10.1001/archsurg.142.5.456.
   PubMedGoogle Scholar
• Murphy AD, Britten A, Powell B. Hot or not? The 10% rule in sentinel lymph node biopsy for malignant melanoma revisited. J Plas Reconstruct Aesthet Surg. 2014;67(3):316–319. doi: 10.1016/j.bjps.2013.11.008.
   PubMed Web of Science ®Google Scholar
• Emery RE, Stevens JS, Nance RW, et al. Sentinel node staging of primary melanoma by the “10% rule”: pathology and clinical outcomes. Am J Surg. 2007;193(5):618–622. doi: 10.1016/j.amjsurg.2007.01.001.
   PubMed Web of Science ®Google Scholar
• Kroon HM, Lowe L, Wong S, et al. What is a sentinel node? Re-evaluating the 10% rule for sentinel lymph node biopsy in melanoma. J Surg Oncol. 2007;95(8):623–628. doi: 10.1002/jso.20729.
   PubMed Web of Science ®Google Scholar
• Pijpers R, Borgstein PJ, Meijer S, et al. Transport and retention of colloidal tracers in regional lymphoscintigraphy in melanoma: influence on lymphatic mapping and sentinel node biopsy. Melanoma Res. 1998;8(5):413–418. doi: 10.1097/00008390-199810000-00005.
   PubMed Web of Science ®Google Scholar
• Even-Sapir E, Lerman H, Lievshitz G, et al. Lymphoscintigraphy for sentinel node mapping using a hybrid SPECT/CT system. J Nucl Med. 2003;44(9):1413–1420.
   PubMed Web of Science ®Google Scholar
• Uren RF. SPECT/CT lymphoscintigraphy to locate the sentinel lymph node in patients with melanoma. Ann Surg Oncol. 2009;16(6):1459–1460. doi: 10.1245/s10434-009-0463-z.
   PubMed Web of Science ®Google Scholar
• Moncrieff M, Pywell S, Snelling A, et al. Effectiveness of SPECT/CT imaging for sentinel node biopsy staging of primary cutaneous melanoma and patient outcomes. Ann Surg Oncol. 2022;29(2):767–775. doi: 10.1245/s10434-021-10911-4.
   PubMed Web of Science ®Google Scholar
• Hunting AS, Nopp A, Johansson SG, et al. Anaphylaxis to patent blue V. I. Clinical aspects. Allergy. 2010;65(1):117–123. doi: 10.1111/j.1398-9995.2009.02192.x.
   PubMed Web of Science ®Google Scholar
• Leong SP, Donegan E, Heffernon W, et al. Adverse reactions to isosulfan blue during selective sentinel lymph node dissection in melanoma. Ann Surg Oncol. 2000;7(5):361–366. doi: 10.1007/s10434-000-0361-x.
   PubMed Web of Science ®Google Scholar
• Karim RZ, Scolyer RA, Li W, et al. False negative sentinel lymph node biopsies in melanoma may result from deficiencies in nuclear medicine, surgery, or pathology. Ann Surg. 2008;247(6):1003–1010. doi: 10.1097/SLA.0b013e3181724f5e.
   PubMed Web of Science ®Google Scholar